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Rac and Rho Mediate Opposing Hormonal Regulation
of the Ether-A-Go-Go-Related Potassium Channel
eases [1]. G protein signaling cascades have emerged
as one of the primary cellular mechanisms for controlling
ion channels [2]. Previous studies of ion channel regula-
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National Institute of Environmental tion by G proteins have focused on the larger, hetero-
trimeric GTPases, which are activated by heptahelicalHealth Sciences
Research Triangle Park, North Carolina 27709 receptors for hormones and neurotransmitters at the
cell surface [3]. However, the primary effectors for many
of the heterotrimeric G proteins have not been identified.
For example, many Gq-coupled receptors stimulateSummary
phospholipase C but regulate channel activity through
mechanisms which apparently do not involve the sec-Background: Previous studies of ion channel regulation
ond messengers generated by phospholipase C [4–6].by G proteins have focused on the larger, heterotrimeric
In contrast, most studies of the Rho family of GTPases,GTPases, which are activated by heptahelical mem-
which are activated by guanine nucleotide exchangebrane receptors. In contrast, studies of the Rho family
factors (GEFs) inside the cell, have focused on their roleof smaller, monomeric, Ras-related GTPases, which are
in cytoskeletal changes, such as those accompanyingactivated by cytoplasmic guanine nucleotide exchange
neurite extension and retraction in the developing ner-factors, have focused on their role in cytoskeletal regu-
vous system [7, 8]. Only a few studies [9–11] have re-lation.
ported ion channel regulation by the smaller, mono-
meric, Ras-related G proteins, but those studies did notResults: Here we demonstrate novel functions for the
investigate the specificity of the responses. Here weRho family GTPases Rac and Rho in the opposing hor-
describe specific novel functions for the Rho GTPasesmonal regulation of voltage-activated, ether-a-go-go-
Rac and Rho in the opposing regulation of voltage-related potassium channels (ERG) in a rat pituitary cell
dependent potassium channels by hormones whichline, GH4C1. The hypothalamic neuropeptide, thyrotro-
control electrical excitability of endocrine cells in thepin-releasing hormone (TRH) inhibits ERG channel activ-
pituitary.ity through a PKC-independent process that is blocked
Rat pituitary cell lines, which spontaneously fire longby RhoA(19N) and the Clostridium botulinum C3 toxin,
trains of overshooting action potentials, are widely stud-which inhibit Rho signaling. The constitutively active,
ied models for ion channel regulation by G protein-cou-GTPase-deficient mutant of RhoA(63L) rapidly inhibits
pled receptors [12]. One class of voltage-activated po-the channels when the protein is dialysed directly into
tassium channel in particular, the ether-a-go-go relatedthe cell through the patch pipette, and inhibition persists
gene channel (KCNH2 or “ERG”), has a pivotal role inwhen the protein is overexpressed. In contrast, GTPase-
regulating spiking in the pituitary and in heart muscle,deficient Rac1(61L) stimulates ERG channel activity. The
because of its unique gating kinetics [13, 14]. For exam-thyroid hormone triiodothyronine (T3), which antago-
ple, inhibition of the ERG channels by either inheritednizes TRH action in the pituitary, also stimulates ERG
mutations or prescription drugs dramatically increaseschannel activity through a rapid process that is blocked
the risk of fatal cardiac arrhythmias [15, 16], but theby Rac1(17N) and wortmannin but not by RhoA(19N).
physiological regulators of ERG channels in the heart
remain to be identified. In contrast, in native lactotrophsConclusions: Rho stimulation by G13-coupled receptors and in clonal pituitary cell lines, ERG channels are knownand Rac stimulation by nuclear hormones through PI3-
to be suppressed by G protein-coupled receptors forkinase may be general mechanisms for regulating ion
the hypothalamic neuropeptide, thyrotropin-releasingchannel activity in many cell types. Disruption of these
hormone (TRH), which stimulates excitability and secre-novel signaling cascades is predicted to contribute to
tion [13]. Our study began as an investigation of theseveral specific human neurological diseases, including
mechanism of ERG channel inhibition by TRH.epilepsy and deafness.
Introduction Results
By determining membrane potential and calcium influx, Potassium current through active ERG channels was
ion channels control brain activity, hormone secretion, isolated with the protocol illustrated in Figure 1 (see
heart rate, and muscle contractility. In addition, ion Experimental Procedures). Separation was confirmed
channels regulate fluid transport across epithelia and with the methane-sulfonanilide E-4031, a class III antiar-
cell fate in the immune system. Thus, cellular control of rhythmic which selectively inhibits ERG channels [14].
ion channel activity is essential to maintaining physio- Under these conditions, bath application of TRH rapidly
logical homeostasis, and inherited mutations in ion reduced the ERG current (Figure 1B), producing 50%
channel proteins contribute to many serious human dis- reduction of the peak current within 3 min of perfusion
(Figure 1C). Other effects of TRH on pituitary excitability
have been attributed to signaling through Gq-coupled1Correspondence: armstro3@niehs.nih.gov
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receptors and the second messengers produced by
phospholipase C [17, 18], but the pharmacological evi-
dence for and against ERG channel regulation by protein
kinase C is inconclusive [19, 20]. We tested the involve-
ment of the ser/thr protein kinases PKA and PKC by
repeating the measurements in the presence of 100 nM
PKA inhibitor peptide (amide 6-22) to inhibit PKA or in
the presence of 50 nM calphostin C to inhibit all PKC
isoforms [21]. The response to TRH was not reduced
by blocking either of the kinases (Figure 1C); in fact,
TRH was even more effective when PKC was blocked.
Many hormones that activate Gq have also been ob-
served to stimulate G13 [22], which, in turn, has been
shown to stimulate Rho through a specific Rho GEF,
p115 [23]. Therefore, we considered an alternative sig-
naling pathway for ERG channel inhibition by TRH recep-
tors involving Rho stimulation by G13.
Rho Mediates ERG Inhibition by TRH
GH4C1 cells were transiently transfected with plasmids
encoding constitutively active mutants of G13 and RhoA
(Figure 2A), in which GTPase activity was blocked by
an amino acid substitution in the active site [3]. In G13
(QL) transfected cells, the control ERG current amplitude
was chronically reduced by50%, which is comparable
to the reduction produced by acute application of TRH.
Mock transfected controls or cells transfected with wild-
type G13 did not show any reduction in control cur-
rent amplitudes. Transfection with constitutively active
RhoA(63L) was even more effective than TRH or G13(QL)
at reducing the ERG current. Overnight transfection with
RhoA(63L) completely eliminated ERG current in the ma-
jority of cells (n  12/20) and reduced the ERG current
in the remaining cells to 6 pA/pF (n  8). In contrast,
transfection with another constitutively active Rho fam-
ily member, Rac1(61L), produced a 25% increase rather
than a decrease in the control current amplitude (Figure
2A) and did not prevent inhibition by TRH (data not
shown).
ERG channels were also inhibited acutely by direct
intracellular application of active RhoA(63L) protein.
When constitutively active RhoA protein (3 g/ml) was
included in the patch pipette, the ERG current was re-
duced to 19% of control values (n  5/5) within 10 min
after beginning dialysis of the cell (Figure 2B). Although
ERG amplitude also decreased over that timescale in
control cells, the reduction of current with RhoA(63L)
protein in the pipette was at least three times greater
than the rundown observed with the control pipette solu-
tion (Figure 2C). These results provide the first demon-
stration of ERG channel regulation by a specific Rho
family G protein, and they are consistent with a role for
Rho in TRH action.
amplitude of the initial voltage step for three consecutive series of
voltage steps applied to the same cell. Bath application of 1 M
Figure 1. ERG Current Reduction by TRH Does Not Require PKA TRH for 5 min reduced the ERG currents () at all voltages compared
or PKC Activity to the basal current (). The current remaining in TRH was blocked
by 10 M E-4031 (H17009).(A) ERG current was isolated by a series of voltage steps (top panel,
see Experimental Procedures). Addition of 10 M E-4031 (lower (C) Peak ERG currents before (white) and 2–3 min after bath applica-
tion of 1 M TRH (hatched) in control cells and in cells exposed topanel) selectively blocked the ERG current.
(B) Peak inward current amplitude at 100mV is plotted versus the inhibitors of PKA (PKI) or PKC (calphostin C).
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The involvement of Rho in TRH signaling was tested
further by the overexpression of a dominant-negative
form (19N) of RhoA, which prevents activation of endog-
enous Rho by forming unproductive complexes with the
Rho GEFs [24]. Cells transfected overnight with domi-
nant-negative RhoA(19N) did not show TRH-induced
ERG inhibition (Figure 2D). This effect was specific to
Rho because overexpression of dominant-negative
Rac1(17N) did not prevent ERG inhibition by TRH. Fur-
thermore, acute inactivation of endogenous Rho pro-
teins by ADP ribosylation with Clostridium botulinum C3
toxin [25] added to the patch pipette also prevented
inhibition of ERG channels by TRH (Figure 2D). Thus,
activation of Rho is sufficient to inhibit the channels as
effectively as TRH, and Rho is required for TRH to inhibit
them. By inhibiting ERG channels, Rho could mediate
the well characterized stimulation of action potential
frequency by TRH [12]. Conversely, hormones that stim-
ulate ERG channels would be predicted to inhibit excit-
ability.
Rapid Membrane Signaling by Thyroid Hormone
In the pituitary, the stimulatory effects of hypothalamic
TRH on excitability are counteracted in part through
feedback inhibition by the thyroid hormone 3, 5,
3-triiodothyronine (T3) [26]. Many of the effects of T3
have been shown to be mediated by binding directly to
nuclear receptors of the c-ErbA family of zinc finger
transcription factors [26]. However, more recently, many
electrophysiological effects of other nuclear hormones
have been reported, which occur too rapidly to be ex-
plained by nuclear signaling [27]. Thus, we investigated
whether T3 could rapidly alter the excitability of GH4C1
cells. Consistent with this idea, bath application of T3
(50 nM) to spontaneously spiking GH4C1 cells acutely
and reversibly reduced spike frequency (n 7/7, Figures
3A and 3B). In contrast, the same concentration of the
reverse 3, 3, 5 isomer of T3, which binds to the ErbA
receptor with much lower affinity [26], had no effect on
spiking in GH4C1 cells (n  3; data not shown). The
reversible changes in excitability were observed within
10 min and seemed too fast to be explained by transcrip-
tional regulation. We also investigated whether T3 mod-
ulated ERG channel activity. Bath application of 50 nM
T3 rapidly increased inward currents at100mV (Figure
3C). These larger currents were blocked completely by
E-4031, confirming the involvement of ERG channels.
Thus, T3 and TRH activate opposing signaling pathways
that converge on ERG channel proteins and produce
opposite effects on excitability.
patch pipette. Although the cell on the right had a larger current
than the control cell at 1 min, active RhoA(63L) protein in the patch
pipette solution produced a much larger reduction in ERG current
over the same 10 min period.
(C) Quantitative summary of all the data from experiments like the
one illustrated in (B), plotting peak ERG current at 100mV.
Figure 2. Rho Mediates ERG Inhibition by TRH
(D) Percentage of control ERG current remaining 5 min after expo-
(A) ERG current amplitude in cells transfected with recombinant sure to 1 M TRH. The reduction of control currents by TRH was
GTPases. prevented by dialysis with the bacterial ADP ribosyl transferase C3
(B) Representative whole-cell records of ERG currents from two or by transfection with a dominant-negative RhoA(19N) but not by
cells 1 min and 10 min after beginning dialysis of the cell with the Rac(17N). *Significantly different from control, p  0.005.
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Rac Mediates ERG Stimulation by T3
In view of the opposing actions of Rac and Rho on other
processes [8], we postulated that Rac might mediate
the effects of T3 on ERG channel activity. We had already
observed that transfection with constitutively active
Rac1(61L) increased the ERG current in GH4C1 cells (Fig-
ure 2A), in direct contrast to active RhoA(63L), which
reduced the current. We confirmed this result by addi-
tion of constitutively active Rac1(61L) to the patch pi-
pette (Figure 4A). Despite the rundown of the control
currents over a period of 10 min, Rac1(61L) protein pro-
duced a 63% increase in the current, all of which passed
through ERG channels because it was blocked com-
pletely by E-4031 (Figure 4B). Thus, the opposite effects
of Rac1 and RhoA on the ERG channels correspond
closely to the opposite effects of T3 and TRH. We tested
the involvement of Rac in T3 signaling with a dominant-
negative form (17N) of Rac1. Although addition of
Rac1(17N) protein to the patch pipette had no significant
effect on the basal currents (n  8; data not shown),
expression of Rac1(17N) completely blocked T3 stimula-
tion of ERG channels (Figure 4C). In contrast, in control
experiments, T3 increased ERG current by 38%  14%
(n  5) after expression of the dominant-negative
RhoA(19N), which blocked TRH signaling (Figure 2D).
These results indicate that Rac1 is specifically re-
quired for T3 stimulation of ERG channels, but there is
no widely accepted mechanism for Rac activation by
T3 or by any other nuclear family hormones. However,
we noted a recent report that receptors for nuclear family
hormones, including T3, activate PI3-kinase directly
through binding to the p85 regulatory subunit [28]. Acti-
vation of PI3-kinase has been shown to stimulate Rac
activity through activation of Rac guanine exchange fac-
tors [29]. Therefore, we hypothesized that T3 stimulation
of ERG channels might be mediated by PI3-kinase acti-
vation of Rac. In support of our hypothesis, inhibition
of PI3-kinase with 20 nM wortmannin [30] completely
blocked ERG stimulation by T3 (Figure 4C). Although 20
nM wortmannin also reduced basal ERG currents (Figure
4B), it did not prevent active Rac1(63L) in the pipette
from increasing the ERG current by over 30% (Figure
4B), consistent with our hypothesis that PI3-kinase acts
upstream of Rac.
Discussion
The convergence of Rac and Rho signaling on an identi-
fied potassium channel (ERG or KCNH2), which can be
assayed quantitatively in situ, provides a unique oppor-
tunity for elucidating the downstream effectors of these
two central cytoplasmic signaling molecules. ERG chan-
nels regulate the excitability of native endocrine cells
[13], and, although GH4C1 cells do not correspond di-
(B) Smaller 30 s sections of the record in (A) showing the changes
Figure 3. Triiodothyronine (T3) Rapidly Slows Spontaneous Action in action potential frequency and amplitude on an expanded
Potential Frequency and Stimulates ERG Channels in GH4C1 Cells timescale.
(A) Current-clamp recording of spontaneous electrical activity re- (C) The current-voltage relationship from a representative cell 1 min
corded for 23 min during constant perfusion. Transient application before () and 5 min after () bath application of T3 (50 nM). The
of 50 nM T3 reduced the action potential frequency in a reversible T3-induced current increase was blocked by 10M E-4031 (H17009) while
manner. T3 was present.
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rectly to any one specific cell type in the pituitary, they
have well characterized receptors and secretory re-
sponses to TRH and to T3 [17, 31]. We have demon-
strated here that dominant-negative forms of the
GTPases selectively block hormone signaling, and con-
stitutively active forms of the GTPases fully reproduce
the opposing effects of the hormones on ERG channel
activity. Furthermore, both Rac and Rho act rapidly
when the proteins are dialysed directly into the cell
through the patch pipette, and their effects persist when
the proteins are overexpressed.
In other cells, Rho produces many of its effects on
cytoskeletal organization through protein kinases [32].
In the mammalian neuroendocrine system, potassium
channel inhibition by other ser/thr protein kinases has
been widely documented [2], and ser/thr-directed pro-
tein phosphatase activity is required for reversal of TRH
signaling in GH4C1 cells [33]. Whether Rho kinases act
directly on the channels or indirectly through inhibition
of protein phosphatases [34], RhoA activation by G13
could regulate ERG channels in heart muscle and other
potassium channels in other cell types [4–6], such as the
“M” type potassium channels (KCNQ2/3) in brain, which
are mutated in various forms of human epilepsy [35].
Our data indicating a requirement for Rac in potas-
sium channel stimulation by thyroid hormone could also
explain the rapid effects of thyroid hormone [36] and
other nuclear hormones on excitability of other cell types
[27]. Although Rac effectors have not been character-
ized as extensively as Rho effectors [3, 8], one Rac
effector of interest in this context is phospholipase A2
[37]. Arachidonic acid metabolites have been reported
to mediate hormonal stimulation of potassium channels
through a ser/thr protein phosphatase [38, 39], which
could also mediate Rac antagonism of Rho kinase ac-
tion. Regardless of the mechanism of Rac action, our
discovery that Rac is as essential for potassium channel
stimulation by thyroid hormone as it is for neurite exten-
sion in the developing nervous system [8] provides the
first potential molecular explanation for the develop-
mental neurological deficits associated with thyroid hor-
mone receptor mutations [26, 40], iodine-deficient diets,
and environmental exposures to industrial organochlo-
rine compounds, which reduce circulating levels of thy-
roid hormone [41].
Conclusions
The data presented here demonstrate novel roles for
Rac and Rho in the regulation of ERG potassium chan-
nels by the thyroid hormone, triiodothyronine, and the
Figure 4. Rac1 Is Both Necessary and Sufficient for Stimulation of hypothalamic neuropeptide, thyrotropin-releasing hor-
ERG Channels by Triiodothyronine (T3) mone. Rho stimulation by G13-coupled receptors and
(A) The current-voltage relationship from a typical cell 1 min () and Rac stimulation by nuclear hormones through PI3 kinase
10 min () after dialysis from a patch pipette containing active may be general mechanisms for regulating ion channel
Rac1(61L). The Rac-stimulated current was blocked completely by
activity in many cell types. Disruption of these novelsubsequent bath application of 10 M E-4031 (H17009).
signaling cascades by environmental toxicants is pre-(B) Peak ERG currents elicited by steps to20mV after 1 min (open)
dicted to contribute to several human neurological dis-and after 10 min (shaded) dialysis of Rac1(61L) from the patch pi-
pette into the cell. Quantitatively similar results were obtained after eases.
bath application of 20 nM wortmannin.
(C) Percent change in ERG current amplitude 5 min after exposure Experimental Procedures
to 50 nM T3. Expression of dominant-negative Rac1(17N) or bath
application of 20 nM wortmannin prevented ERG stimulation by T3. Cells and Reagents
GH4C1 cells were plated onto glass coverslips (Deutsche spielglas,
Carolina Biological, Burlington, NC) in DMEM/F-12 with 10% calf
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